DMAC NASDAQ
DiaMedica Therapeutics Inc.
1W: +0.2%
1M: +4.5%
3M: +37.5%
YTD: +9.6%
1Y: +26.3%
3Y: +304.2%
5Y: +111.4%
$8.69
-0.05 (-0.57%)
Weekly Expected Move ±8.4%
$7
$8
$9
$9
$10
Credit Risk of going bust: lower than 90% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), DiaMedica Therapeutics Inc. would be worth roughly what it owes.
Total debt $185K against a stock market value of $468.6M.
Distance to default 13.95 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $150K (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -8.04. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), DiaMedica Therapeutics Inc. would be worth roughly what it owes.
Total debt $185K against a stock market value of $468.6M.
Distance to default 13.95 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $150K (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -8.04. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-06-29
Earliest Filing
2022-06-29
Latest Filing
supplier: 1
Counterparties (Filed by DMAC)
1 relationshipsCompanies named in DMAC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Medica Services Company, LLC | — | supplier | Landlord providing office space under a lease agreement | 2022-06-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-05-21 | Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-03-31 | Earnings Release; Exhibits | View | |
| 2026-01-05 | Other Events | View | |
| 2025-12-18 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-06 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Other Events; Fi | View | |
| 2025-07-21 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-07-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-05-15 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-24 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-06-26 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR